Discovery of a dual Ras and ARF6 inhibitor from a GPCR endocytosis screen.
Saved in:
| Title: | Discovery of a dual Ras and ARF6 inhibitor from a GPCR endocytosis screen. |
|---|---|
| Authors: | Giubilaro J; Department of Pharmacology and Therapeutics, McGill University, Montréal, QC, Canada.; Research Institute of the McGill University Health Center (RI-MUHC), Montreal, QC, Canada., Schuetz DA; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, Canada., Stepniewski TM; Research Programme on Biomedical Informatics (GRIB), Department of Experimental and Health Sciences of Pompeu, Fabra University (UPF)-Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.; InterAx Biotech AG, Villigen, Switzerland., Namkung Y; Research Institute of the McGill University Health Center (RI-MUHC), Montreal, QC, Canada.; Department of Medicine, Research Institute of the McGill University Health Center (RI-MUHC), McGill University, Montréal, QC, Canada., Khoury E; Department of Medicine, Research Institute of the McGill University Health Center (RI-MUHC), McGill University, Montréal, QC, Canada., Lara-Márquez M; Research Institute of the McGill University Health Center (RI-MUHC), Montreal, QC, Canada.; Department of Anatomy and Cell Biology, McGill University, Montréal, QC, Canada., Campbell S; Department of Pharmacology and Physiology, Université de Montréal, Montréal, QC, Canada., Beautrait A; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, Canada.; Schrödinger, Inc., New York, NY, United States., Armando S; Department of Medicine, Research Institute of the McGill University Health Center (RI-MUHC), McGill University, Montréal, QC, Canada., Radresa O; Department of Medicine, Research Institute of the McGill University Health Center (RI-MUHC), McGill University, Montréal, QC, Canada., Duchaine J; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, Canada., Lamarche-Vane N; Research Institute of the McGill University Health Center (RI-MUHC), Montreal, QC, Canada.; Department of Anatomy and Cell Biology, McGill University, Montréal, QC, Canada., Claing A; Department of Pharmacology and Physiology, Université de Montréal, Montréal, QC, Canada., Selent J; Research Programme on Biomedical Informatics (GRIB), Department of Experimental and Health Sciences of Pompeu, Fabra University (UPF)-Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Bouvier M; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, Canada.; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, Canada., Marinier A; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, Canada., Laporte SA; Department of Pharmacology and Therapeutics, McGill University, Montréal, QC, Canada. stephane.laporte@mcgill.ca.; Research Institute of the McGill University Health Center (RI-MUHC), Montreal, QC, Canada. stephane.laporte@mcgill.ca.; Department of Medicine, Research Institute of the McGill University Health Center (RI-MUHC), McGill University, Montréal, QC, Canada. stephane.laporte@mcgill.ca. |
| Source: | Nature communications [Nat Commun] 2021 Aug 03; Vol. 12 (1), pp. 4688. Date of Electronic Publication: 2021 Aug 03. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34344896 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Discovery of a dual Ras and ARF6 inhibitor from a GPCR endocytosis screen. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Giubilaro+J%22">Giubilaro J</searchLink>; Department of Pharmacology and Therapeutics, McGill University, Montréal, QC, Canada.; Research Institute of the McGill University Health Center (RI-MUHC), Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Schuetz+DA%22">Schuetz DA</searchLink>; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Stepniewski+TM%22">Stepniewski TM</searchLink>; Research Programme on Biomedical Informatics (GRIB), Department of Experimental and Health Sciences of Pompeu, Fabra University (UPF)-Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.; InterAx Biotech AG, Villigen, Switzerland.<br /><searchLink fieldCode="AU" term="%22Namkung+Y%22">Namkung Y</searchLink>; Research Institute of the McGill University Health Center (RI-MUHC), Montreal, QC, Canada.; Department of Medicine, Research Institute of the McGill University Health Center (RI-MUHC), McGill University, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Khoury+E%22">Khoury E</searchLink>; Department of Medicine, Research Institute of the McGill University Health Center (RI-MUHC), McGill University, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Lara-Márquez+M%22">Lara-Márquez M</searchLink>; Research Institute of the McGill University Health Center (RI-MUHC), Montreal, QC, Canada.; Department of Anatomy and Cell Biology, McGill University, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Campbell+S%22">Campbell S</searchLink>; Department of Pharmacology and Physiology, Université de Montréal, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Beautrait+A%22">Beautrait A</searchLink>; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, Canada.; Schrödinger, Inc., New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Armando+S%22">Armando S</searchLink>; Department of Medicine, Research Institute of the McGill University Health Center (RI-MUHC), McGill University, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Radresa+O%22">Radresa O</searchLink>; Department of Medicine, Research Institute of the McGill University Health Center (RI-MUHC), McGill University, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Duchaine+J%22">Duchaine J</searchLink>; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Lamarche-Vane+N%22">Lamarche-Vane N</searchLink>; Research Institute of the McGill University Health Center (RI-MUHC), Montreal, QC, Canada.; Department of Anatomy and Cell Biology, McGill University, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Claing+A%22">Claing A</searchLink>; Department of Pharmacology and Physiology, Université de Montréal, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Selent+J%22">Selent J</searchLink>; Research Programme on Biomedical Informatics (GRIB), Department of Experimental and Health Sciences of Pompeu, Fabra University (UPF)-Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Bouvier+M%22">Bouvier M</searchLink>; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, Canada.; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Marinier+A%22">Marinier A</searchLink>; Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Laporte+SA%22">Laporte SA</searchLink>; Department of Pharmacology and Therapeutics, McGill University, Montréal, QC, Canada. stephane.laporte@mcgill.ca.; Research Institute of the McGill University Health Center (RI-MUHC), Montreal, QC, Canada. stephane.laporte@mcgill.ca.; Department of Medicine, Research Institute of the McGill University Health Center (RI-MUHC), McGill University, Montréal, QC, Canada. stephane.laporte@mcgill.ca. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2021 Aug 03; Vol. 12 (1), pp. 4688. <i>Date of Electronic Publication: </i>2021 Aug 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34344896 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-021-24968-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4688 Titles: – TitleFull: Discovery of a dual Ras and ARF6 inhibitor from a GPCR endocytosis screen. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Giubilaro J – PersonEntity: Name: NameFull: Schuetz DA – PersonEntity: Name: NameFull: Stepniewski TM – PersonEntity: Name: NameFull: Namkung Y – PersonEntity: Name: NameFull: Khoury E – PersonEntity: Name: NameFull: Lara-Márquez M – PersonEntity: Name: NameFull: Campbell S – PersonEntity: Name: NameFull: Beautrait A – PersonEntity: Name: NameFull: Armando S – PersonEntity: Name: NameFull: Radresa O – PersonEntity: Name: NameFull: Duchaine J – PersonEntity: Name: NameFull: Lamarche-Vane N – PersonEntity: Name: NameFull: Claing A – PersonEntity: Name: NameFull: Selent J – PersonEntity: Name: NameFull: Bouvier M – PersonEntity: Name: NameFull: Marinier A – PersonEntity: Name: NameFull: Laporte SA IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 08 Text: 2021 Aug 03 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 12 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |